Study, 2006
Does paroxetine treat premenstrual dysphoric disorder?
Yes. Paroxetine is an antidepressant medication approved by the FDA and Health Canada for treating PMDD.
What they did
Reviewed information about paroxetine and how it fits into treatment guidelines for PMDD, including its approval status.
What they found
PMDD affects 3-8% of women of reproductive age. Symptoms include depressed mood, irritability, anxiety, and physical symptoms that appear during the luteal phase (after ovulation) and go away within 3 days of the period starting. Treatment guidelines recommend lifestyle changes first, then medications. Paroxetine is an antidepressant and was recently approved by the US FDA and Health Canada specifically for PMDD.
What it means for you
If lifestyle changes alone don't relieve your PMDD, paroxetine is an FDA-approved medication option that's recommended as a first-line treatment. This is a review of information, not evidence from a treatment trial.
3-8%
women with PMDD
About the study
- Original title
- Paroxetine use in the treatment of premenstrual dysphoric disorder
- Authors
- Misri S, Kendrick K
- Journal
- Women's health (London, England)
- Year
- 2006
- Study design
- Study
- What was tested
- paroxetine for treating PMDD
- Open access
- Yes
- Read the paper
- doi.org/10.2217/17455057.2.1.43
Topics
Related studies
Systematic review, 2026
Does continuous paroxetine or birth control work better for PMDD?
Systematic review, 2026
Are there differences in brain activity in women with PMDD?
Study, 2026
Are SSRIs the first treatment doctors recommend for PMDD?
Randomised trial, 2025
Does taking an antidepressant only during the second half of your cycle reduce anger and aggression in PMDD?
Systematic review, 2024
What are the best treatments for PMDD and PMS?
Review, 2024
What are the most effective treatments for PMDD?